Magnetic resonance imaging combined with serum endolipin and galactagoglobin-3 to diagnose cerebral infarction in the elderly with diabetes mellitus

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Jul 15, 2024; 15(7): 1509-1517
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1509

Table 2 Comparison of serum endolipin and galactagoglobin-3 expression in the two groups

Group	Visfatin (µg/L)	Gal-3 (ng/mL)
Diabetic cerebral infarction group (n = 62)	36.58 ± 8.12	10.58 ± 3.48
Non-diabetic cerebral infarction group (n = 88)	26.13 ± 6.82	6.28 ± 2.39
t	8.536	8.975
P value	< 0.001	< 0.001

Gal-3: Galactagoglobin-3.

Citation: Zhang YH, Liang D. Magnetic resonance imaging combined with serum endolipin and galactagoglobin-3 to diagnose cerebral infarction in the elderly with diabetes mellitus. World J Diabetes 2024; 15(7): 1509-1517
URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1509.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1509

Zhang YH, Liang D. Magnetic resonance imaging combined with serum endolipin and galactagoglobin-3 to diagnose cerebral infarction in the elderly with diabetes mellitus. World J Diabetes 2024; 15(7): 1509-1517 [PMID: 39099812 DOI: 10.4239/wjd.v15.i7.1509]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.